Race against frostbite: everest doctors test Life-Saving drug on the mountain
NCT ID NCT07450469
Summary
This study aims to see if a drug called iloprost, which can help save frostbitten tissue, can be given safely and effectively at remote high-altitude locations like Everest Basecamp. Researchers will treat up to 10 adult climbers with severe frostbite within 72 hours of injury and monitor them for side effects and long-term outcomes like amputation rates. The goal is to understand the logistical challenges and see if starting treatment on-site, rather than after evacuation, leads to better tissue preservation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALTITUDE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Eurac Research, Institute of Mountain Emergency Medicine
Bolzano, BZ, 39100, Italy
Conditions
Explore the condition pages connected to this study.